Anke Stuurman

Anke Stuurman is the Head of Bacterial Program at P95, where they previously served as a Senior Epidemiologist and team lead. They have an extensive background in epidemiology, having worked as an Epidemiologist at P95 from 2015 to 2022 and as a Junior Researcher at RIVM and Pallas Health Research and Consultancy earlier in their career. Anke completed a Doctor of Philosophy in Influenza Vaccine Effectiveness at the University of Antwerp and holds a Master of Science in Epidemiology from Universiteit Utrecht, achieving a perfect GPA. Anke's expertise includes various aspects of epidemiological research, including post-marketing vaccine safety studies and systematic literature reviews.